A Multicenter Randomized 52 Week Treatment Double-blind, Triple Dummy Parallel Group Study to Assess the Efficacy and Safety of QMF149 Compared to Mometasone Furoate in Patients With Asthma
Phase of Trial: Phase III
Latest Information Update: 08 Jan 2018
At a glance
- Drugs Indacaterol/mometasone (Primary) ; Mometasone; Salmeterol/fluticasone propionate
- Indications Asthma
- Focus Registrational; Therapeutic Use
- Sponsors Novartis; Novartis Pharma A.G.
- 30 Sep 2016 Planned End Date changed from 1 Aug 2018 to 1 Oct 2018.
- 30 Sep 2016 Planned primary completion date changed from 1 Aug 2018 to 1 Oct 2018.
- 08 Apr 2016 Planned End Date changed from 1 Apr 2018 to 1 Aug 2018 as reported by ClinicalTrials.gov.